Rmr Wealth Builders Nektar Therapeutics Transaction History

Rmr Wealth Builders

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$16.52 - $20.4 $1,106 - $1,366	-67 Closed	0 $0
Q4 2020 Feb 26, 2021	BUY	$15.77 - $19.03 $1,056 - $1,275	67 New	67 $1,000
Q3 2020 Nov 13, 2020	SELL	$16.59 - $24.79 $1,111 - $1,660	-67 Closed	0 $0
Q4 2019 Mar 03, 2020	BUY	$15.87 - $23.12 $1,063 - $1,549	67 New	67 $1,000

146

140M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $157M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Rmr Wealth Builders, based on Form 13F filings with the SEC.

Stay updated on Rmr Wealth Builders with notifications on news.